BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 16437388)

  • 1. Cell cycle alterations and lung cancer.
    Vincenzi B; Schiavon G; Silletta M; Santini D; Perrone G; Di Marino M; Angeletti S; Baldi A; Tonini G
    Histol Histopathol; 2006 Apr; 21(4):423-35. PubMed ID: 16437388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular genetics of small cell lung carcinoma.
    Wistuba II; Gazdar AF; Minna JD
    Semin Oncol; 2001 Apr; 28(2 Suppl 4):3-13. PubMed ID: 11479891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular genetics of human lung cancer.
    Slebos RJ; Rodenhuis S
    Eur Respir J; 1989 May; 2(5):461-9. PubMed ID: 2547647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular biology of lung cancer.
    Kaye FJ
    Lung Cancer; 2001 Dec; 34 Suppl 2():S35-41. PubMed ID: 11720739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A translational view of the molecular pathogenesis of lung cancer.
    Sato M; Shames DS; Gazdar AF; Minna JD
    J Thorac Oncol; 2007 Apr; 2(4):327-43. PubMed ID: 17409807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [2000 Standards, Options and Recommendations for prognostic value of oncogenes and tumor suppressor genes in non small cell lung cancer].
    Bréchot JM; Molina T; Theobald S; Depierre A; Lagrange JL; Astoul P; Baldeyrou P; Bardet E; Bazelly B; Breton JL; Douillard JY; Grivaux M; Jacoulet P; Khalil A; Lemarié E; Martinet Y; Massard G; Milleron B; Moro-Sibilot D; Paesmans M; Pujol JL; Quoix AE; Ranfaing E; Rivière A; Sancho-Garnier H; Souquet PJ; Spaeth D; Stcebner-Delbarre A;
    Bull Cancer; 2002 Oct; 89(10):857-67. PubMed ID: 12441277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular abnormalities in lung cancer.
    Salgia R; Skarin AT
    J Clin Oncol; 1998 Mar; 16(3):1207-17. PubMed ID: 9508209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance of cyclin Dl expression in non-small cell lung cancer].
    Dworakowska D
    Pneumonol Alergol Pol; 2005; 73(3):297-300. PubMed ID: 16989170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p27KIP1 in human lung cancers: differential changes in small cell and non-small cell carcinomas.
    Yatabe Y; Masuda A; Koshikawa T; Nakamura S; Kuroishi T; Osada H; Takahashi T; Mitsudomi T; Takahashi T
    Cancer Res; 1998 Mar; 58(5):1042-7. PubMed ID: 9500468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transition from SCLC to NSCLC phenotype is accompanied by an increased TRE-binding activity and recruitment of specific AP-1 proteins.
    Risse-Hackl G; Adamkiewicz J; Wimmel A; Schuermann M
    Oncogene; 1998 Jun; 16(23):3057-68. PubMed ID: 9662339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein expression of the RB-related gene family and SV40 large T antigen in mesothelioma and lung cancer.
    Modi S; Kubo A; Oie H; Coxon AB; Rehmatulla A; Kaye FJ
    Oncogene; 2000 Sep; 19(40):4632-9. PubMed ID: 11030152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse models for human lung cancer.
    Meuwissen R; Berns A
    Genes Dev; 2005 Mar; 19(6):643-64. PubMed ID: 15769940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biology of small-cell bronchogenic carcinoma: recent advances].
    Levy R; Andrieu JM; Even P
    Bull Cancer; 1992; 79(1):25-46. PubMed ID: 1325850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer.
    Osada H; Takahashi T
    Oncogene; 2002 Oct; 21(48):7421-34. PubMed ID: 12379883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenes in human lung cancer.
    Kratzke RA; Shimizu E; Kaye FJ
    Cancer Treat Res; 1992; 63():61-85. PubMed ID: 1363367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene amplification in human lung cancer. The myc family genes and other proto-oncogenes and growth factor genes.
    Bergh JC
    Am Rev Respir Dis; 1990 Dec; 142(6 Pt 2):S20-6. PubMed ID: 2174659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular pathogenesis of lung cancer and potential translational applications.
    Minna JD; Fong K; Zöchbauer-Müller S; Gazdar AF
    Cancer J; 2002; 8 Suppl 1():S41-6. PubMed ID: 12075701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RB and cyclin dependent kinase pathways: defining a distinction between RB and p16 loss in lung cancer.
    Kaye FJ
    Oncogene; 2002 Oct; 21(45):6908-14. PubMed ID: 12362273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering.
    Girard L; Zöchbauer-Müller S; Virmani AK; Gazdar AF; Minna JD
    Cancer Res; 2000 Sep; 60(17):4894-906. PubMed ID: 10987304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cell cycle, tumor suppressor genes and lung cancers].
    Bréchot JM
    Rev Mal Respir; 1998 Sep; 15(4):461-6. PubMed ID: 9805756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.